General Updates

Ref. No.: LASA/SE/26-27/17 Wednesday September 09, 2026 To, To, Corporate Services Department Corporate Services Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra-Kurla Complex, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. BSE CODE –540702 NSE CODE: LASA Dear Sir/Madam, Sub: Outcome of Board Meeting held today i.e. September 09, 2026 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors at their meeting held today which commenced at 03.00 pm and concluded at 5.00 pm have considered and approved the following: 1) The Notice of the Eleventh (11th ) Annual general Meeting (AGM) of the Company 2) The 11th AGM is scheduled to be held on Wednesday, September 30, 2026 at 9:30 A.M. through Video conferencing (VC) / Other Audio-Visual means (OAVM). 3) The Director’s Report of the Company together with Report on Corporate Governance, Management Discussion and Analysis Report and other relevant annexures & Schedules thereto for the financial year ended March 31, 2026. 4) Appointment of Shravan A. Gupta & Associates, Practicing Company Secretaries as a scrutinizer for 11th Annual General Meeting. 5) Re-Appointment of Mr. Omkar Herlekar (DIN: 01587154), Director who is liable to retire by rotation and eligible for re-appointment. 6) To close Register of Members and Share Transfer Books of the Company from Wednesday 23rd September 2026 to Tuesday 29th September 2026 both days inclusive. The above information is also available on the company’s website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com. FOR LASA SUPERGENERICS LIMITED OMKAR HERLEKAR CHAIRMAN AND MANAGING DIRECTOR DIN: 01587154 AS REQUIRED UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 DETAILS OF RE-APPOINTMENT OF THE AFORESAID DIRECTORS ARE ENCLOSED AS AN ANNEXURE. Name of Director Dr. Omkar Pravin Herlekar Director Identification No. 01587154 Date of Birth March 13,1981 Date of appointment on Board May 02, 2017 Nationality Indian Qualifications Doctorate in Philosophy (Science) from the Institute of Chemical Technology, Mumbai and a degree of Masters of Science (By Research) (Theory) from University of Mumbai Expertise in specific functional Dr. Omkar P. Herlekar is the Chairman and Managing areas Director of Lasa Supergenerics Limited. Upon assuming the leadership of Lasa, Dr. Herlekar charted a multi-pronged approach for its corporate growth. Envisioning a global presence for the group, Dr. Herlekar played a pivotal role in establishing marketing set-up across and outside India. Lasa places immense focus on research. Dr. Herlekar has played a pivotal role in embryonic the group’s ‘Catalyst Chemistry’ division that focuses on development of veterinary APIs and breakthrough innovations. His contributions are widely acclaimed in the industry circles. Under his leadership, Lasa achieved new milestones and offered several innovations with the help of ‘backward integration’. Herlekar’ visionary and astute entrepreneurial leadership resulted in Lasa emerging as one of the leading animal healthcare conglomerates in India, driven by research, and strategic thinking on a global scale. His clear vision, steady guidance and boundless passion for organic chemistry serve as catalysts for the steady and continued expansion of the group. He also holds number of ‘process patents’ to his credit. Dr. Herlekar spearheads business development, expansion initiatives, financial management, investment and regulatory affairs. He has a team of experienced technocrats who are dedicated towards scaling the group to greater heights through innovation and excellence, thereby creating value for its stakeholders. List of Directorships held in Other Companies (Excluding Nil Foreign, Private and Section 8 Companies) Memberships/ Chairmanships of Membership – 2 (Two):- in Audit Committee and Audit and Stakeholders’ Stakeholders’ Relationship Committee of Lasa Supergenerics Relationships Committees across Limited Member in Audit Committee Public Companies Number of shares held in the 26879650 Company Relationships between the N.A Directors inter-se FOR LASA SUPERGENERICS LIMITED OMKAR HERLEKAR CHAIRMAN AND MANAGING DIRECTOR DIN: 01587154 LASA SUPERGENERICS LIMITED NOTICE CIN: L24233MH2016PLC274202 Registered Address: Plot no. C-4, C-4/1, MIDC Lote Parshuram Industrial Area, Tal -Khe, Dist- Ratnagiri, Khed, Maharashtra, India, 415722 Mail Id: cs@lasalabs.com Contact No: +91 7798888147 NOTICE IS HEREBY GIVEN THAT THE ELEVENTH (11TH) ANNUAL GENERAL MEETING (AGM) OF THE MEMBERS OF LASA SUPERGENERICS LIMITED WILL BE HELD ON WEDNESDAY, SEPTEMBER 30, 2026 AT 09:30 AM (IST) THROUGH VIDEO CONFERENCING (VC/ OTHER AUDIO VISUAL MEANS (OAVM) FACILITY TO TRANSACT THE FOLLOWING BUSINESS: ORDINARY BUSINESS: Item No.1 ADOPTION OF ANNUAL ACCOUNTS To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditors thereon; Item No.2 APPOINTMENT OF A DIRECTOR RETIRING BY ROTATION To appoint a Director in place of Mr. Omkar Herlekar (DIN: 01587154), who is liable to retire by rotation and being eligible, offers himself for re-appointment. SPECIAL BUSINESS Item No. 3: APPOINTMENT OF SECRETARIAL AUDITOR AND APPROVAL OF HIS REMUNERATION. To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 204 and other applicable provisions of the Companies Act, 2013, if any and Rule 9 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 24A and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), and based on the recommendation of the audit committee and approval of the Board of Directors, consent of the shareholders be and is hereby accorded for appointment of Mr. Shivam Sharma (ACS No. 35727; COP No. 16558) of Ms. Shivam Sharma & Associates, Practicing Company Secretary, as secretarial auditor of the Company for one term of 5 consecutive years i.e. from financial year 2025-26 to financial year 2029-30 (‘the Term’), to conduct secretarial audit of the Company and to furnish the secretarial audit report and secretarial compliance report; RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorised to fix the annual remuneration plus applicable taxes and out-of pocket expenses payable to her during her tenure as the secretarial auditor of the Company, as determined by the audit committee and the Board in consultation with the said secretarial auditor; RESOLVED FURTHER THAT the Board of Directors of the Company (including and committee thereof) be and is hereby authorised to do all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give effect to this resolution.” Item No.4: APPOINTMENT OF MR. JANARDAN SAVALA, (DIN: 11913583), AS THE WHOLE-TIME DIRECTOR, DESIGNATED AS ‘EXECUTIVE DIRECTOR FOR A TERM OF 5 YEARS COMMENCING FROM AUGUST 26, 2026. To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Sections 196, 197, 203 and other applicable provisions, if any, of the Companies Act, 2013 (“the Act”) read with the Rules made thereunder, including any statutory modification(s) or re-enactment(s) thereof for the time being in force, and subject to such approvals, permissions and sanctions as may be required, consent of the Members of the Company be and is hereby accorded to the [Showing first 8,000 characters — download PDF for full document]